-
Hunter QIU
Equity Partner / Shanghai
-
Tel +86-21-6061-3725
Email hunterqiu@zhonglun.com
-
Practices

Cross-border Investment/M&A, Litigation & Arbitration, Compliance & Investigation
-
Industries

Telecom & Information, Intelligence Technology & Application, Pharmaceuticals & Life Sciences
Hunter QIU
Mr. Qiu's main practice areas are Cross-border Investment/M&A, Litigation & Arbitration, and Compliance & Investigation.
Representative Matters
M&A, Joint Venture, and Corporate Transactions
Hunter advises multinational corporations and PE/VC funds on cross-border M&As, joint ventures, carve-out, and spin-off transactions in manufacturing, high-tech, life science, cosmetics, entertainment, food and beverage, and other sectors. His representative deals include:
Advised IBM on its acquisition of the iPaaS business from Software AG
Advised Carlyle on its proposed acquisition of the patient monitoring and respiratory intervention business from Medtronic
Advised AppLovin on its acquisition of a gaming studio in China
Advised Johnson Controls International (JCI) on the formation of an auto interiors joint venture with Yanfeng Automotive Interiors in the Shanghai Free Trade Zone
Advised Standard Motor Products on its acquisition of Nissens Automotive from Axcel
Advised Dairy Queen on the trade sale of its South China master franchisee from Warburg Pincus and a Chinese developer to EQT Partners Asia
Advised the owners of Granite River Labs on the sale of their controlling shares to SFW Capital
Advised Crown Bioscience on the sale of its CVMD business to Innoland Bio
Advised Key Safety Systems on the restructuring of its joint ventures in China for the purpose of offshore listing (later sold to Joyson Electronics)
Advised Cartesian Capital on the restructuring and sale of its shares in a China-based joint venture manufacturing heavy-duty diesel engines
Advised a U.S. medical device company on the formation of a joint venture in China to manufacture medical device consumables
Advised an Ohio based industrial equipment manufacturer on the sale of non-controlling equity to its Chinese joint venture partner
Advised a California life science company on the liquidation of its Chinese subsidiary
Compliance, Internal Investigation, and Government Enforcement
Hunter frequently teams up with regulatory or compliance specialists in advising multinational companies on internal compliance investigations and regulatory compliance matters in China. His representative cases include:
Represented a Nasdaq listed company in an internal investigation into alleged receipt by its China manager of kickbacks from third-party vendors
Advised a Silicon Valley company on an investigation into the fraudulent obtaining of a High-tech Company designation in China using fake patents and fabricated R&D expenses, and related tax risks
Advised a global auto part manufacturer on an investigation involving cashing-out of housing and transportation allowances
Advised a German company on an investigation into embezzlement, misappropriation of company funds, and other misconduct committed by its China CEO
Advised a U.S. Big Pharma on compliance risks under China's anti-commercial bribery laws
Advised a U.S. Big Pharma on government investigation into alleged false or misleading advertising
Advised a well-known multinational on responding to whistleblower cases initiated by former employees
Advised a U.S. franchisor on an internal FCPA investigation involving a director (a former government official) of its Chinese master franchisee
Advised a Fortune 500 company on potential successor liability under the FCPA antibribery provision relating to its acquisition of a Chinese company controlled by the child of a high-ranking government official
Advised a Fortune 500 company on an internal investigation involving the channel stuffing practice of its Chinese subsidiaries
Advised several Fortune 500 companies on investigations by the Chinese environmental protection authorities into violations of environmental laws by China subsidiaries
Cross-border Dispute Resolution
Hunter frequently teams up with local trial lawyers in lawsuits and arbitration proceedings in China, U.S., and other jurisdictions. His representative cases include:
Advised GA Telesis, an aircraft part manufacturer, on PRC law in a lawsuit brought by a Chinese party before the U.S. District Court for the Southern District of Florida
Represented the Chinese controlling shareholder of a Sino-US joint venture in its settlement negotiation with the U.S. shareholder relating to an alleged breach of the joint venture agreement and related-party transactions
Represented U.S. trading company CAET in a dispute with a trading company in Hangzhou over breach of contract
Represented a U.S. holder of convertible bonds in resolving a dispute arising out of unauthorized conversion of the bond into preferred shares by the bond issuer, a Cayman company
Represented Libre Wireless in a lawsuit involving breach of contract claims in Shenzhen
Represented a U.S. franchisor in settlement negotiation regarding an alleged breach by the China franchisee of the master franchise agreement
Represented a Swiss importer in a CIETAC arbitration in connection with a dispute resulting from a sale-of-goods contract
Represented a Hong Kong trading company in its petition to Beijing No.2 Intermediate Court to vacate an unfavorable CIETAC arbitration award on the grounds of procedural defects
Memberships & Affiliations
Member, American Bar Association
Member, All China Lawyers Association
Member, Shanghai Bar Association
Publications
"Franchising: International Overview – China", Thomson Reuters, 2019
"China Proposes to Simplify Foreign Investments in Listed Cos", Law360, August 21, 2018
"§10 Stock Incentive Plans, Venture Capital & Private Equity in China" (co-author with Joseph Chan), LexisNexis, 2008
Related
-
Articles Related
Regulatory Compliance: A New Era for China's Biotech Innovation
The Regulation sets unified rules for clinical studies and translational applications of new biomedical technologies.
2025-12-01
-
Bar Admissions/Professional Qualifications
New York State Bar
PRC Bar -
Education
Washington University in St. Louis, J.D. (with honors)
University of International Business and Economics (Beijing), Master of Laws
Harbin University of Commerce, Bachelor of Laws -
Professional Experience
Equity Partner, Zhong Lun Law Firm, 2016 to present
Corporate Attorney, Cooley, Jones Day, Baker McKenzie, and Pillsbury Winthrop Shaw Pittman, prior to 2016
Extern, U.S. Securities and Exchange Commission, 2012 -
Languages
Chinese
English